ctrl K

Price Alert

Astria Therapeutics Inc. (ATXS)

NASDAQ: ATXS · Real-Time Price · USD

6.85

0.09 (1.33%)

At close: Aug 15, 2025, 3:59 PM

6.85

0.00%

After-hours: Aug 15, 2025, 04:10 PM EDT

Astria Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	59.82M	175.53M	20.52M	86.51M
Short-Term Investments	268.31M	71M	205.91M	39M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.61M	3.36M	2M	45K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	6.51M	163K	n/a	121K
Total Current Assets	334.64M	250.94M	227.69M	127.08M
Property-Plant & Equipment	5.11M	363K	948K	394K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.72M	3.72M	2.94M	439K
Total Assets	342.36M	254.67M	230.63M	127.51M
Account Payables	4.32M	1.51M	788K	1.56M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	1.38M	329K	582K	365K
Other Current Liabilities	-1.38M	3.72M	3.73M	1.59M
Total Current Liabilities	19.13M	11.55M	9.06M	5.2M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.97M	n/a	357K	1.92M
Total Liabilities	23.1M	11.55M	9.42M	5.2M
Total Debt	5.35M	329K	939K	365K
Common Stock	57K	41K	28K	13K
Retained Earnings	-674.79M	-580.53M	-507.64M	-455.81M
Comprehensive Income	163K	n/a	-79K	n/a
Shareholders Equity	319.26M	243.12M	221.22M	122.31M
Total Investments	268.31M	71M	205.91M	39M